Literature DB >> 2472353

Analysis of a subclass-restricted HIV-1 gp41 epitope by omission peptides.

T Mathiesen1, F Chiodi, P A Broliden, J Albert, R A Houghten, G Utter, B Wahren, E Norrby.   

Abstract

To define the amino acids involved in IgG subclass reactivity to two overlapping HIV-1 gp41 (E34/32; amino acid positions 582-613) peptides, sera from 18 HIV-infected individuals were studied. Peptides mimicking E34 but with single amino acid deletions or glycine substitutions were used to define the amino acid residues necessary for antibody binding. Two dominating immunogenic epitopes, containing highly hydrophilic amino acids, were found on the original peptide. Further analysis was undertaken with two corresponding omission sets of dodecapeptides representing halves of the complete E34 plus a terminal cystein peptide. The subclass reactivities usually differed between the patients with regard to the epitopes with which the different IgG subclasses reacted and also to the importance of different amino acids in antibody binding. The 600 glycine and the 601 lysine were involved in the binding of all IgG1, 2 and 4 and most IgG3. The development of E34/32-reactive IgM and IgG subclasses showed different patterns in four patients with primary HIV infections, contradicting the existence of a general pattern for the development of IgG subclasses to this peptide. The findings suggest that different progenitor clones are selected for synthesis of the different subclasses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472353      PMCID: PMC1385279     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Non-sequential expression of multiple immunoglobulin classes by isolated B-cell clones.

Authors:  P J Gearhart
Journal:  Nature       Date:  1977-10-27       Impact factor: 49.962

2.  Strategies for epitope analysis using peptide synthesis.

Authors:  H M Geysen; S J Rodda; T J Mason; G Tribbick; P G Schoofs
Journal:  J Immunol Methods       Date:  1987-09-24       Impact factor: 2.303

3.  Mimicking the alloantigenicity of proteins with chemically synthesized peptides differing in single amino acids.

Authors:  H Alexander; D A Johnson; J Rosen; L Jerabek; N Green; I L Weissman; R A Lerner
Journal:  Nature       Date:  1983 Dec 15-21       Impact factor: 49.962

4.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

5.  Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.

Authors:  R C Aalberse; R van der Gaag; J van Leeuwen
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

6.  The potential of B lymphocytes for isotype expression.

Authors:  J M Teale
Journal:  Fed Proc       Date:  1982-07

7.  Neutralization capacity and antibody dependent cell-mediated cytotoxicity of separated IgG subclasses 1, 3 and 4 against herpes simplex virus.

Authors:  T Mathiesen; M A Persson; V A Sundqvist; B Wahren
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

8.  IgG subclass reactivity against human immunodeficiency virus (HIV) and cytomegalovirus in cerebrospinal fluid and serum from HIV-infected patients.

Authors:  T Mathiesen; A Sönnerborg; M von Sydow; H Gaines; B Wahren
Journal:  J Med Virol       Date:  1988-05       Impact factor: 2.327

9.  Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein.

Authors:  F Chiodi; A von Gegerfeldt; J Albert; E M Fenyö; H Gaines; M von Sydow; G Biberfeld; E Parks; E Norrby
Journal:  J Med Virol       Date:  1987-09       Impact factor: 2.327

10.  Human beta-endorphin: synthesis and characterization of analogs iodinated and tritiated at tyrosine residues 1 and 27.

Authors:  R A Houghten; W C Chang; C H Li
Journal:  Int J Pept Protein Res       Date:  1980-10
View more
  4 in total

1.  Herpesvirus serology, aberrant specific immunoglobulin G2 and G3 subclass patterns and Gm allotypes in individuals with low levels of IgG3.

Authors:  A Linde; R Söderström; C I Smith; M Sällberg; H Dahl; R Grubb; J Björkander; L Hammarström
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.

Authors:  H Siitari; P Turunen; J Schrimsher; M Nunn
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

3.  Designing a soluble near full-length HIV-1 gp41 trimer.

Authors:  Guofen Gao; Lindsay Wieczorek; Kristina K Peachman; Victoria R Polonis; Carl R Alving; Mangala Rao; Venigalla B Rao
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

Review 4.  HIV-1-specific antibody responses during acute and chronic HIV-1 infection.

Authors:  Georgia D Tomaras; Barton F Haynes
Journal:  Curr Opin HIV AIDS       Date:  2009-09       Impact factor: 4.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.